Deccan Health Care Ltd. · BSE:DECCAN
Deccan Health Care — Q2 & H1 FY25 Earnings Presentation
38 slides from Deccan Health Care's earnings presentation, Nov 15, 2024
Slide 1: Cover letter to BSE on Investors' Presentation
Date: 15 November 2024 To, Corporate Relationship Department, BSE Limited PJ Towers, Dalal Street, Mumbai 400001, MH Stock Code: 542248 Subject: Investors’ Presentation on Financial Results for the Quarter ended 30 September 2024 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligation
Slide 2: Investor Presentation Q2 & H1 FY25
Investor Presentation Q2 & H1 FY25 BSE: 542248 S e pte m b e r 2024
Slide 3: Safe Harbor
Safe Harbor This presentation has been prepared by Deccan Health Care Limited (“Company") solely for information purposes without any regard to any specific objective, financial situation, or informational need of any particular person. This presentation may not be copied, distributed, or disseminat
Slide 4: Presentation Content
Presentation Content Q2 & H1 FY25 Financials Recently Product Launched Company Profile Annexure
Slide 5: Message from the MD's Desk
Message from the MD’s Desk Commenting on the results, Dr. Minto Purshotam Gupta, Chairman & Managing Director of Deccan Health Care Limited said, “We have delivered impressive growth in Q2 FY25, achieving a revenue of ₹1,882.1 lakhs, representing a 25% increase QoQ and a 9.5% rise YoY. This strong r
Slide 6: Q2 & H1 FY25 Financials
Q2 & H1 FY25 Financials Key Business Highlights Financials Performance Half Yearly Product Launch
Slide 7: Key Business Highlights
Key Business Highlights ᢰ Quarterly Performance: • Revenue increased by 25% QoQ to ₹1,882.1 lakhs, and by 9.5% YoY. Goss Profit grew by 18.2% QoQ and 8.8% YoY to ₹745.6 lakhs, with a margin of 39.6%. • EBITDA improved by 27.5% QoQ and 7.7% YoY to ₹110.9 lakhs, while the EBITDA Margin was at 5.9%. PA
Slide 8: Key Business Highlights
Key Business Highlights ᢰ Tackling Anemia with Natural Solutions: Straya's Iron Fruit Bar and Collaborative Efforts: • To support the government’s Anemia Mukt Bharat (AMB) initiative, a collaboration between the CSIR and the Ministry of Science & Technology has resulted in the creation of Straya – B
Slide 9: Quarterly Financial Performance
Quarterly Financial Performance ₹ in Lakh Revenue Gross Profit & Margin(%) 25% QoQ 18.2% QoQ 1,882 1,720 1,506 746 685 631 39.8% 41.9% 39.6% Q2FY24 Q1FY25 Q2FY25 Q2FY24 Q1FY25 Q2FY25 EBITDA & Margin(%) PAT & Margin(%) 27.5% QoQ 45.6% QoQ 103 111 87 53 54 37 6.0% 5.8% 5.9% 3.1% 2.4% 2.9% Q2FY
Slide 10: H1 FY25 Financial Performance
H1 FY25 Financial Performance ₹ in Lakh Revenue Gross Profit & EBITDA & Margin(%) PAT & Margin(%) Margin(%) 19.2% YoY 9.2% YoY 6.7% YoY 7.5% YoY 3,388 2,842 1,377 1,261 198 185 91 84 44.4% 40.6% 6.5% 5.8% 3.0% 2.7% H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 Q2 & H1 FY25 www.decc
Slide 11: Yearly Financial Performance
Yearly Financial Performance ₹ in Lakh Revenue Gross Profit & EBITDA & Margin(%) PAT & Margin(%) Margin(%) 5,973 2,225 4,502 2,005 376 152 206 44.5% 37.3% 40 6.3% 4.6% 2.5% 0.9% FY23 FY24 FY23 FY24 FY23 FY24 FY23 FY24 YoY Growth 32.7% 11.0% 82.8% 3.8x Margin Expansion (729) bps +173 bps +166 bps Q2
Slide 12: Unveiling the Nutri Care Range - Addressing Evolving Needs
Recently Product Launched Unveiling the Nutri Care Range - Addressing Evolving Needs WELLBEING PRODUCTS PERSONAL CARE WELLNESS PRODUCTS NUTRI FOODS SELF CARE Herbal + Natural Body Health Supplements+Nutraceuticals FMCHP Category Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 13: Experience Exceptional Nutrition Through DHCL BRANDS
Recently Product Launched Experience Exceptional Nutrition Through DHCL BRANDS ᢰ Transformative Wellness Journey: DHCL BRANDS offers products that embody our dedication to exceptional nutrition, combining premium ingredients, scientific expertise, and unparalleled flavor. ᢰ Precision and Passion: Ea
Slide 14: Meticulously Crafted Nutrient-Rich Snack
Recently Product Launched - NUTRI FOODS Meticulously Crafted Nutrient - Rich Snack Oats & Multiseed Sesame & Elaichi Millet Cookies Millet Cookies Coconut Almond Ashwagandha Flax Millet Cookies Millet Cookies Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 15: Empowering Body Health
Recently Product Launched - PERSONAL CARE & SELF CARE Empowering Body Health NoFall Omega 3 GlowDecc Sundecc Hair Oil Brightening Cream Sun Screen Cream GlowDecc Vitamin C Italian Rose Royal Tea Tree Face Serum Body Wash Body Wash Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 16: Bringing together the touch of nature with herbal science
Recently Product Launched - WELLBEING PRODUCTS Bringing together the touch of nature with herbal science Respidecc Livodecc Respiratory Support Liver Tonic Step into a world where the essence of nature intertwines seamlessly with the precision of herbal science. Our Wellbeing product line embodies t
Slide 17: Company Profile
Company Profile About DHCL Value Chain Business Verticals Our Journey Scaling Approach Growth Contributing Factor Growth Drivers Leadership Team
Slide 18: About DHCL: Purpose of Nutritional Solutions
About DHCL It Starts with a Purpose - of Nutritional Solutions R&D focus - the Deccan Differentiator Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 19: We make everyday quality of life more awesome
About DHCL We make everyday quality of life more awesome Launch Portfolio Growth Quality Consumer Reach Established in 1996, a With a robust portfolio of Migrated to Main Board Certifications include Our one-stop destination leading Fast Moving 1500 market-ready Platform of BSE in 2023. CGMP, FSSAI,
Slide 20: Value Chain: 'Better Together' solution
Value Chain An innovative 'Better Together' solution that enhances opportunities for value creation. Deccan Health Care’s Presence in the Value Chain Raw Processing Product Manufacturing Product Revenue & Distribution Consumer Materials Materials Formulation Production Packaging & Labelling Channels
Slide 21: Deccan is well-positioned to lead the industry
Business Verticals Deccan is well-positioned to lead the industry & Deliver shareholder value Capabilities ᢰ Resiliency tested and validated over the past 20 years; proven track • Softgels • Hardgels record of delivering growth • Tablets • Lotions • Creams • Pastes ᢰ Strong organic growth profile dr
Slide 22: Our Journey: Steady Evolution Into Comprehensive Nutrition Solution
Our Journey Steady Evolution Into Comprehensive • Shipment of "Stay Young" brand products to Mauritius and Kenya Nutrition Solution in 2018. • FIDSI Charter Membership • In 2016, Launched “Be Young” brand & • Share allotted on “Preferential E-commerce platform Basis” of ₹5 Cr in 2021 www.Beyoungstor
Slide 23: Revenue Channel I: E-Commerce (BeYoungStore)
Scaling Approach Revenue Channel I: E-Commerce (BeYoungStore) ᢰ Team Lead: Mr. O P Verma with Area-wise leaders ᢰ Growth Strategy: Geography Expansion, Appointment of new Distributor and Wellness Consultants [DWC], Home Shops [HS], and more products in unrepresented categories. ᢰ Supply Chain Module
Slide 24: Revenue Channel II: Private Label; Channel III: Export
Scaling Approach Revenue Channel II: Private Label Manufacturing ᢰ Team Lead: Mr. Mohak Gupta supported by Dr. Siddharth Pandey ᢰ Top Customers: House of Masaba Lifestyle, Modicare, Plus Plus Lifesciences, General Medicine & Therapeutics, MRL Pharma, Pranasa Mediworld, Quora Pharmaceuticals, Pranisc
Slide 25: Revenue Channel IV: Online Marketplace
Scaling Approach Revenue Channel IV: Online Marketplace ᢰ Team Lead: Ms. Mohita Gupta ᢰ Discover premium wellness solutions tailored for discerning customers on the online marketplaces Amazon & www.otcfirst.in ᢰ Our curated selection of Nutridecc and Organowild brand products caters to select geogra
Slide 26: Growth Contributing Factors
Growth Contributing Factors Advancing Innovation Strategic Board Expansion Optimizing Manufacturing R&D and Product for Enhanced Governance Capabilities for Growth Pipeline and Growth Dr. Minto P Gupta Mr. Mohak Gupta ᢰ Our current products are ᢰ Upgrading our manufacturing facility to ᢰ Expanding t
Slide 27: Navigating Growth: Driven by Quality and Dependability
Growth Drivers Navigating Growth: Driven by Quality and Dependability ᢰ Focus on Compliance & Regulation: By adhering to regulatory standards like FSSAI in India and the Dietary Supplement Health and Education Act (DSHEA), we ensure the quality and safety of our products. This commitment to complian
Slide 28: Navigating Growth: Expansion Initiatives
Navigating Growth: Expansion Initiatives Deccan Health Care Limited is focused on translating state-of-the-art scientific research into long-lasting nutritional solutions. Operating in the rapidly growing nutraceuticals supplement industry, fueled by growing health consciousness and a preference for
Slide 29: Leadership Team
Leadership Team • Dr. Minto Purshotam Gupta is a Ph.D. in • Masters of Science in Education Extension from the Microbiology, Cellular Biochemistry, Naturopathic Maharaja Sayajirao University of Baroda. Medicine, Phytochemicals, Administrative Services • Worked on World Health Organisation (WHO) Proj
Slide 30: Leadership Team - Board of Directors
Leadership Team - Board of Directors Ruchi Khattar Samhitha Kandlakunta Independent Director Independent Director • Alumnus of Lady Shri Ram College, Delhi University • MBA in Finance from the University of Dallas, Texas, USA, and a PG Diploma in Alternative Dispute Resolution from NALSAR University
Slide 31: Leadership Team - Board of Directors
Leadership Team - Board of Directors Umanja Venkata Satya Siva Srihari Kolla Ramesh Kumar Non-Executive Director Independent Director • Founder of Sreenidhi Group in real estate, Aruntech Solutions Pvt Ltd, & • PG in PM & IR from Xavier Institute of Social Service, complemented by his SKB&SVR Memori
Slide 32: Leadership Team – Key Managerial Personnel
Leadership Team – Key Managerial Personnel Mr. Parth H Palera Ms. Vaishali Gagnani Chief Financial Officer Company Secretary & Compliance Officer • As the Chief Financial Officer of Accounts & Finance, Mr. Parth H. Palera is • As the Company Secretary & Compliance Officer for Legal & Compliance, Ms.
Slide 33: Accolades
Accolades Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 34: Accolades
Accolades Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 35: Accolades
Accolades Q2 & H1 FY25 www.deccanhealthcare.co.in
Slide 36: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars Quarterly Half-Yearly Yearly (₹ in Lakh) Q2 FY25 Q1 FY25 QoQ Q2 FY24 YoY H1 FY25 H1 FY24 YoY FY24 Total Income 1,882.2 1,506.1 25.0% 1,719.5 9.5% 3,388.3 2,842.4 19.2% 5,974.3 Raw Material Cost 1,075.1 629.8 366.9 1,704.9 894.9 3,046.5 Inc./(Dec.) in In
Slide 37: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement ₹ in Lakh Assets H1 FY25 FY24 Equity & Liabilities H1 FY25 FY24 Non-Current Assets 1,922.3 1,987.5 Equity 9,930.1 9,703.7 Property Plant & Equipments 1,502.1 1,567.6 Share Capital 2,098.0 2,037.7 Investments 1.0 1.0 Other Equity 7,832.1 7,666.0 Intangible Assets 1.
Slide 38: Thank You!
Thank You! GET IN TOUCH WITH US Deccan Health Care Limited Dr. Minto Purshotam Gupta Chairman & Managing Director E: [email protected] W: www.deccanhealthcare.co.in Rik Consultancy & Advisory Services LLP Mr. Ritesh Shashiprakash Singh Investor Relations Consultant M: +91 83293 85762 E: rit
Deccan Health Care — Q2 & H1 FY25 Earnings Presentation on 6ix